"448-patient Phase 2 clinical trial in osteoarthritis expected to commence in 2H 2019"
"This trial will be one of the largest MSC trials ever run, representing a breakthrough achievement for Cynata and showcasing its capacity to produce MSCs at scale"
'Trial will take place in Sydney and Tasmania"
Ann: NHMRC Funding for Osteoarthritis Trial Using Cymerus MSCs, page-3
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.5¢ |
Change
-0.010(3.92%) |
Mkt cap ! $44.01M | |||
| Open | High | Low | Value | Volume |
| 25.5¢ | 25.5¢ | 24.5¢ | $23.65K | 94.55K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 40000 | 25.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 26.0¢ | 36715 | 1 |
View Market Depth
| Last trade - 15.10pm 29/07/2024 (20 minute delay) ? |
| CYP (ASX) Chart |